Genesys Capital
Overview
Genesys Capital is a prominent Canadian venture capital firm with over 25 years of experience, focusing on early-stage investments in the life sciences sector. The firm has successfully raised over $400 million across five funds and has been a founding investor in 80% of its portfolio companies. Notable recent exits include Inversago Pharma, acquired by Novo Nordisk for $1.4 billion, and Fusion Pharmaceuticals, acquired by AstraZeneca for $3.3 billion. These successes highlight Genesys' ability to generate fund-level returns driven by local Canadian innovation. The firm's investment strategy emphasizes co-creating and investing in disruptive Canadian life science opportunities, leveraging its deep scientific network and long-standing partnerships with leading North American research institutes and universities. This approach provides early access to top-tier discoveries and high-potential deal flow, enabling Genesys to build pioneering companies that compete on a global scale. With a proven team and a consistent company creation investment strategy, Genesys Capital continues to set the standard for life sciences venture capital in Canada, committed to building world-class companies and delivering exceptional returns for its investors.
Investment Focus
- Strong scientific foundation
- Innovative solutions addressing unmet medical needs
- Experienced management teams
Portfolio Companies
Get the full list of 54,000+ investors
Genesys Capital and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Genesys Capital
What sectors does Genesys Capital invest in?
Genesys Capital invests in Healthcare, Life Sciences, Pharmaceuticals, Medical Devices and Biotechnology, and is based in Toronto, Ontario, Canada. Genesys Capital is listed as a venture capital in the ConnectSafely investor database.
What stage does Genesys Capital invest at?
Genesys Capital backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Genesys Capital invest in?
Genesys Capital invests across United States and Canada.
Who are the partners at Genesys Capital?
Team members listed for Genesys Capital include Jennifer Williams (Partner and CFO) and Jamie Stiff (Managing Director).
What companies has Genesys Capital invested in?
Genesys Capital's portfolio includes Fusion Pharmaceuticals, Inversago Pharma, CryoStasis Inc, Feldan Therapeutics, Epocal and Questat Inc.
How do I contact Genesys Capital?
Genesys Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
